PTC Therapeutics
PTCT
PTCT
260 hedge funds and large institutions have $4.02B invested in PTC Therapeutics in 2025 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 85 increasing their positions, 94 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
9% more funds holding
Funds holding: 239 → 260 (+21)
0.9% less ownership
Funds ownership: 100.76% → 99.87% (-0.9%)
10% less repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 94
Holders
260
Holding in Top 10
6
Calls
$15.8M
Puts
$12.5M
Top Buyers
| 1 | +$59.6M | |
| 2 | +$37M | |
| 3 | +$35.4M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$31.5M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$29.5M |
Top Sellers
| 1 | -$84.8M | |
| 2 | -$47.8M | |
| 3 | -$47.1M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$39.4M |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$33.6M |